NASDAQ:ICVX

Icosavax News Headlines

$16.51

+0.27 (+1.66%)

(As of 01/14/2022 12:00 AM ET)

Add

Compare

Today's Range: $15.58
▼
$16.61
50-Day Range: $16.24
▼
$28.30
52-Week Range: $15.58
▼
$49.99

Volume: 32,008 shs
Average Volume: 56,873 shs
Market Capitalization: $644.55 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

Get Icosavax News Delivered to You Automatically

Media Mentions By Week

Icosavax Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ICVX
News Sentiment
▼
-0.18

0.31
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ICVX Articles
This Week
▼
3

1
▲
ICVX Articles
Average Week

Icosavax (NASDAQ:ICVX) News Headlines Today

Source

Source	Headline
	CRISPR Therapeutics (NASDAQ:CRSP) & Icosavax (NASDAQ:ICVX) Head to Head Survey americanbankingnews.com - January 15 at 12:16 AM
	Icosavax (NASDAQ:ICVX) Reaches New 1-Year Low at $16.73 americanbankingnews.com - January 13 at 1:46 PM
	Icosavax Inc reuters.com - January 13 at 6:22 AM
	Icosavax outlines anticipated milestones for 2022 seekingalpha.com - January 7 at 9:55 AM
	Icosavax Provides Corporate Update and Anticipated Milestones for 2022 finance.yahoo.com - January 7 at 9:55 AM
	Icosavax Appoints Dr. John Shiver to Board of Directors finance.yahoo.com - January 5 at 9:03 AM
	Icosavax (NASDAQ:ICVX) Shares Gap Down to $22.51 americanbankingnews.com - December 28 at 1:08 PM
	Top Biotech IPOs Of 2021 That Soared As Much As 500% markets.businessinsider.com - December 20 at 1:44 PM
	Icosavax Inc Shares Close the Day 19.6% Higher - Daily Wrap nasdaq.com - November 27 at 7:34 AM
	Icosavax Reports Third Quarter 2021 Financial Results and Provides Corporate Update finance.yahoo.com - November 15 at 5:55 PM
	Icosavax to Participate in Upcoming Investor Conferences finance.yahoo.com - November 11 at 6:53 PM
	What Kind Of Shareholders Hold The Majority In Icosavax, Inc.'s (NASDAQ:ICVX) Shares? nasdaq.com - October 29 at 2:13 PM

	Even though Icosavax, Inc.'s (NASDAQ:ICVX) stock is down 5.2% this week, insiders who bought lately made a US$326k profit finance.yahoo.com - October 29 at 2:13 PM
	Icosavax Reports Second Quarter 2021 Financial Results and Provides Corporate Update finance.yahoo.com - September 13 at 4:41 PM
	Icosavax Appoints Elizabeth Bekiroğlu to General Counsel finance.yahoo.com - September 10 at 8:14 AM
	Icosavax Initiates Phase 1/1b Trial of VLP Vaccine Candidate Against Respiratory Syncytial Virus finance.yahoo.com - September 9 at 8:52 AM
	Icosavax, Inc. Rings the Closing Bell nasdaq.com - August 11 at 9:08 PM
	Icosavax Inc. barrons.com - August 11 at 12:58 AM
	Icosavax Mourns Sudden Passing of Tadataka Yamada, M.D. Chairman of the Company’s Board of Directors finance.yahoo.com - August 10 at 2:57 PM

Get Icosavax News Delivered to You Automatically

This page was last updated on 1/16/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources